Dexcom Inc
NASDAQ:DXCM
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
Market Cap | EV/S | ||||
---|---|---|---|---|---|
US |
Dexcom Inc
NASDAQ:DXCM
|
49.1B USD | 13.5 | ||
US |
Abbott Laboratories
NYSE:ABT
|
183.8B USD | 4.7 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
131.5B USD | 17.3 | ||
US |
Stryker Corp
NYSE:SYK
|
127.9B USD | 6.6 | ||
IE |
Medtronic PLC
NYSE:MDT
|
106.7B USD | 3.8 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
105.3B USD | 7.9 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 4.1 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.1B EUR | 3.1 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
50.9B USD | 8.3 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.1 | ||
US |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
40.9B USD | 11.3 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.